Back to Trades
Smith Ryan Lewis
DirectorCIK: 0001619129
Smith Ryan Lewis, Director, has filed 12 insider trading reports covering 2 companies. Total disclosed trading volume is $15.5M. The predominance of buying activity ($13.1K in purchases vs. $0 in sales) may reflect this insider's confidence in the underlying companies. The largest single filing involves 180 Life Sciences Corp. (ATNF). All transactions sourced from SEC Form 4 filings.
Total Volume
$15.5M
Purchases
$13.1K
Sales
$0
Companies
2
Companies Traded
Trading History (12 filings)
Grant
$0
1 grant
Buy
$13.1K
1 buy
Other
$0
Other
$0
Other
$0
Other
$0
Other
$0
Gift
$0
Grant
$0
1 grant
Other
$0
Other
$0
Other
$0